Anette Sundstedt
Nessuna posizione attualmente
Profilo
Anette Sundstedt served as a Director at Active Biotech AB from 2001 to 2016.
She also held the position of Director at Alligator Bioscience AB from 2021 to 2024.
Dr. Sundstedt was the Chief Scientific Officer at Idogen AB.
Additionally, she served as the Chief Development Officer at CanImGuide Therapeutics AB from 2020 to 2021.
Dr. Sundstedt obtained her graduate and doctorate degrees from the University of Lund.
Precedenti posizioni note di Anette Sundstedt
Società | Posizione | Fine |
---|---|---|
ALLIGATOR BIOSCIENCE AB | Director/Board Member | 07/05/2024 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Corporate Officer/Principal | 01/03/2021 |
ACTIVE BIOTECH AB | Director/Board Member | 01/01/2016 |
IDOGEN AB (PUBL) | Chief Tech/Sci/R&D Officer | - |
Formazione di Anette Sundstedt
University of Lund | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ACTIVE BIOTECH AB | Health Technology |
ALLIGATOR BIOSCIENCE AB | Health Technology |
IDOGEN AB (PUBL) | Health Technology |
Aziende private | 1 |
---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Anette Sundstedt